Management of hepatitis C patients with decompensated liver disease.

about

The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy.

P2860

Q36243096-D2DFE40D-5880-42C4-8E8E-D919F158CA27 Q37208941-D0440D8A-E54E-4645-801B-E072C2851BB6

P2860

Management of hepatitis C patients with decompensated liver disease.

Item

http://www.wikidata.org/entity/Q38702156

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Management of hepatitis C patients with decompensated liver disease.

@en

type

Item

label

Management of hepatitis C patients with decompensated liver disease.

@en

prefLabel

Management of hepatitis C patients with decompensated liver disease.

@en

P1476

Management of hepatitis C patients with decompensated liver disease

@en

P2093

Ching-Sheng Hsu

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma: An update

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

Transmission of hepatitis C virus in Asia: past and present perspectives.

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.

Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.

Interferon-based therapy decreases risks of hepatocellular carcinoma and complications of cirrhosis in chronic hepatitis C patients.

Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma

Re-treatment of chronic hepatitis C virus genotype 1 infection after relapse: an open-label pilot study.

Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis.

Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin.

P304

679-688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17474124.2016.1143775

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jia-Horng Kao

P577

2016-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26782619

http://www.w3.org/2001/XMLSchema#string

Management of hepatitis C patients with decompensated liver disease.

about

P2860

P2860

Management of hepatitis C patients with decompensated liver disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698